1h Free Analyst Time
The drug discovery informatics market is forecasted to grow byUSD 7.28 billion during 2023-2028, accelerating at a CAGR of 18.17% during the forecast period. The report on the drug discovery informatics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing R&D investments by pharmaceutical and biopharmaceutical companies, drug discovery with reduced time and cost by using in-silico modeling tools, and increasing outsourcing activities for drug discovery.
The drug discovery informatics market is segmented as below:
By Application
- Discovery informatics
- Development informatics
By Solution
- Software
- Services
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the drug discovery informatics market covers the following areas:
- Drug discovery informatics market sizing
- Drug discovery informatics market forecast
- Drug discovery informatics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Solution
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global drug discovery informatics market: Aragen Life Sciences Pvt. Ltd., Certara Inc., Charles River Laboratories International Inc., ChemAxon Ltd., ChemBridge Corp., Collaborative Drug Discovery Inc., Cresset BioMolecular Discovery Ltd., Curia Global Inc., Dassault Systemes SE, Eurofins Scientific SE, Evotec SE, Infosys Ltd., Insilico Medicine, International Business Machines Corp., Jubilant Pharmova Ltd., Melissa Inc., OpenEye Scientific Software Inc., PerkinElmer Inc., Schrodinger Inc., Selvita SA, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of clinical trials."
According to the report, one of the major drivers for this market is the increasing R&D investments by pharmaceutical and biopharmaceutical companies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aragen Life Sciences Pvt. Ltd.
- Certara Inc.
- Charles River Laboratories International Inc.
- ChemAxon Ltd.
- ChemBridge Corp.
- Collaborative Drug Discovery Inc.
- Cresset BioMolecular Discovery Ltd.
- Curia Global Inc.
- Dassault Systemes SE
- Eurofins Scientific SE
- Evotec SE
- Infosys Ltd.
- Insilico Medicine
- International Business Machines Corp.
- Jubilant Pharmova Ltd.
- Melissa Inc.
- OpenEye Scientific Software Inc.
- PerkinElmer Inc.
- Schrodinger Inc.
- Selvita SA
- Thermo Fisher Scientific Inc.
